San Francisco, CA, June 26th, 2026, ChainwireFirst public release of a complete FPGA implementation for zero‑knowledge ...
Cheaper proofs may unlock private payments, verifiable AI, digital identity, and on-chain gaming. A team of hardware and ...
BOSTON, June 08, 2026--(BUSINESS WIRE)--Today at the International Microwave Symposium (IMS2026), Altera Corporation, the industry's largest pure-play FPGA solutions provider, announced engineering ...
If you came up building software in the 1990s or early 2000s, you remember the visceral satisfaction of determinism. You wrote code. The compiler analyzed it, optimized it, and emitted precisely the ...
Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...
The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...
With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...
The workplace can be a tricky place to navigate. Almost everything we do at work—identifying the experts, managing tough feedback from a boss, figuring out how to work in teams made up of different ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
The growing use of generative artificial intelligence (GenAI) tools for coding is transforming software engineering practices, with developers now building continuous integration and continuous ...
Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...
Generate:Biomedicines' anti-TSLP antibody GB-0895 is currently being evaluated in a pair of phase 3 studies for severe asthma. (Stock photo/Getty Images) Clinical-stage antibody company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results